Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ, Hillner BE, Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Link H, Zander A, Yanovich S, Kitchin R, Erder MH. Smith TJ, et al. Among authors: boogaerts ma. J Clin Oncol. 1997 Jan;15(1):5-10. doi: 10.1200/JCO.1997.15.1.5. J Clin Oncol. 1997. PMID: 8996118 Clinical Trial.
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.
Kottaridis PD, Peggs K, Schmitz N, Dreger P, Boogaerts MA, Ferrant A, Demuynck HM, Zander A, Link H, Matcham J, Linch DC, Borkett K, Goldstone AH. Kottaridis PD, et al. Among authors: boogaerts ma. Leuk Lymphoma. 2002 Mar;43(3):531-6. doi: 10.1080/10428190290012010. Leuk Lymphoma. 2002. PMID: 12002756 Clinical Trial.
Peripheral blood progenitor cell transplantation: where do we stand? Chairman's Summary of the European School of Oncology Task Force meeting Peripheral Blood progenitor cell's held September 29-30, 1995.
Boogaerts MA, Brugger W, Carella AM, Cortés-Funes H, Fibbe WE, Hows J, Khayat D, Linch DC, Link H, Moore MA, Testa NG. Boogaerts MA, et al. Ann Oncol. 1996;7 Suppl 2:1-4. doi: 10.1093/annonc/7.suppl_2.1. Ann Oncol. 1996. PMID: 8805940 Free article. Review.
A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
Link H, Boogaerts MA, Carella AM, Ferrant A, Gadner H, Gorin NC, Harabacz I, Harousseau JL, Hervé P, Holldack J, et al. Link H, et al. Among authors: boogaerts ma. Blood. 1992 Nov 1;80(9):2188-95. Blood. 1992. PMID: 1421390 Free article. Clinical Trial.
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, Hunter AE, Kanz L, Slavin S, Cornelissen JJ, Gramatzki M, Niederwieser D, Russell NH, Schmitz N. Sureda A, et al. Among authors: boogaerts ma. J Clin Oncol. 2008 Jan 20;26(3):455-62. doi: 10.1200/JCO.2007.13.2415. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086796
Granulocyte growth factors: achieving a consensus.
Boogaerts M, Cavalli F, Cortés-Funes H, Gatell JM, Gianni AM, Khayat D, Levy Y, Link H. Boogaerts M, et al. Ann Oncol. 1995 Mar;6(3):237-44. doi: 10.1093/oxfordjournals.annonc.a059152. Ann Oncol. 1995. PMID: 7542020 Free article. Review.
246 results